Antisense & RNAi Technology Market Research Reports & Industry Analysis
Antisense and RNAi technology has the potential to influence gene expression, offering new possibilities for treating previously challenging diseases. Staying informed about this evolving field is crucial, and MarketResearch.com's reports on the antisense and RNAi technology industry are valuable resources. These reports offer in-depth analyses of industry trends, challenges, and opportunities to help stakeholders make well-informed decisions based on accurate information.
Comprehensive Antisense and RNAi Technology Research
- Find research on a wide spectrum of key market segments including reagents, consumables, RNAi drug delivery, and RNAi therapeutics.
- Gain a holistic view of the industry by delving into RNAi market sizing, growth trajectories, technological breakthroughs, and competitor strategies.
- Understand the trends that are shaping the antisense and RNAi technology industry to stay ahead of the curve in an environment characterized by change.
Why Choose MarketResearch.com
Whether you're a busy executive or a professional in the field, our antisense and RNAi technology market research reports are designed to meet your information needs. These reports offer reliable data to support your business decisions and help you take advantage of emerging market opportunities. Embrace the value of knowledge and confidently explore the potential of the antisense and RNAi technology industry with MarketResearch.com.
Antisense & RNAi Technology Industry Research & Market Reports
-
Antisense & RNAi Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type
... and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is ... Read More
-
Gene Editing Market Forecasts to 2030 – Global Analysis By Product (Software & Systems, Services and Reagents & Consumables), Technology (Transcription Activator-Like Effector Nuclease, Antisense, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nuclease (ZFN) and Other Technologies), Application, End User and By Geography
... (ZFN) and Other Technologies), Application, End User and By Geography According to Stratistics MRC, the Global Gene Editing Market is accounted for $7.45 billion in 2023 and is expected to reach $23.05 billion by 2030 ... Read More
-
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market, By Type (Hereditary Transthyretin Amyloidosis (hATTR), Wild Type Transthyretin Amyloidosis (wtATTR)), By Drug Type (Transthyretin Stabilizers, Nonsteroidal Anti-Inflammatory Drugs (NSAID), RNAi Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Transthyretin amyloid ardiomyopathy (ATTR-CM) is a rare and serious medical condition characterized by the abnormal accumulation of transthyretin ... Read More
-
Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Adoption of ASO Therapeutics for the ... Read More
-
Antisense & RNAi Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028. Antisense therapy is the selective and sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. It ... Read More
-
RNAi Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... period with a CAGR of 9.89% through 2028. The Global RNAi Technology Market is a dynamic and rapidly evolving sector within the biotechnology and pharmaceutical industries. RNA interference (RNAi) technology, a powerful tool for gene ... Read More
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) - Global Forecast to 2028
... projected to grow from USD 13.7 billion in 2023 to USD 18.0 billion by 2028 at a CAGR of 5.6%. The key factors driving the overall market growth include an increase in the number of ... Read More
-
Global RNAi Technology Market - 2023-2030
... period 2023-2030. Small nucleic acid fragments are employed in RNA interference (RNAi), a technology, to post-transcriptionally silence genes and treat cancer and other disorders. Through the use of this technology, proteins that lack the enzyme ... Read More
-
Oligonucleotide Synthesis, Modification and Purification Services Market (2nd Edition): Focus on Research, Diagnostic and Therapeutic Applications, 2021-2031
... have undertaken multiple research initiatives to verify the potential of oligonucleotides as therapeutic agents. The known applications of oligonucleotides in research and diagnostics, in addition to their therapeutic use, have significantly increased. It is worth ... Read More
-
Global miRNA Market 2023-2027
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology [CRISPR, TALEN, Antisense, Zinc Finger Nucleases (ZFNs), and Others], Product and Service (Reagents and Consumables, Instruments, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others)
... Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others) The US & EU gene editing market is projected to ... Read More
-
RNAi Drug Delivery: Technologies and Global Markets
... are divided into polymers, lipids and others (e.g., inorganic material, hybrid systems). The market is also segmented based on the molecule types, delivery modes and therapeutic areas. It is divided by application types into therapeutic ... Read More
-
DNA Synthesis Technologies and Services Market, 2022-2035
... worth highlighting that several research studies are being conducted to evaluate the use of oligonucleotides, especially DNA, as a therapeutic intervention for treatment of various medical conditions. The approval of the first antisense oligonucleotide drug, ... Read More
-
Gene Editing Market by Product & Service (Reagents, Consumables, Systems, Software), Technology (CRISPR, TALEN, ZFN, Antisense), Application (Cell Line Engineering, Genetic Engineering, Drug Discovery), End User (Pharma, Biotech) – Global Forecast to 2028
... editing market is projected to grow from USD 5.3 billion in 2023 to USD 10.6 billion by 2028 at a CAGR of 15.0%. Rising government funding and number of genomics projects has emerged as a ... Read More
-
Global RNAi Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This ... Read More
-
Global RNAi Therapy Supply, Demand and Key Producers, 2023-2029
... (2023-2029). This report studies the global RNAi Therapy demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market for RNAi Therapy, and provides market size (US$ million) ... Read More
-
Genome Editing Market Forecasts to 2028 – Global Analysis By Product & Service (Reagents & Consumables, Services, Software & Systems, Cell Lines and Other Product & Services), By Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nuclease (ZFN), Transcription Activator-Like Effector Nuclease (TALEN), Antisense, Restriction Enzymes and Other Technologies), By Application (Cell Line Editing, Genetic Engineering, Drug Discovery & Development, Diagnostic Applications, Microorganisms Genetic Engineering, Gene Therapy and Other Applications), By End User (Clinical Research Organizations, Academics & Government Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organization and Other End Users) and By Geography
... (CRISPR), Zinc Finger Nuclease (ZFN), Transcription Activator-Like Effector Nuclease (TALEN), Antisense, Restriction Enzymes and Other Technologies), By Application (Cell Line Editing, Genetic Engineering, Drug Discovery & Development, Diagnostic Applications, Microorganisms Genetic Engineering, Gene Therapy and ... Read More
-
RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... IMARC Group expects the market to reach US$ 235.1 Billion by 2028, exhibiting a growth rate (CAGR) of 21.4% during 2023-2028. Ribonucleic acid interference (RNAi) drug delivery refers to a therapeutic solution to monitor gene ... Read More
-
Global RNAi for Therapeutic Market Research Report 2023(Status and Outlook)
... Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. ... Read More
-
RNA Interference Therapy-Competitive landscape, 2023
... product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage RNA Interference Therapy: Understanding RNA Interference Therapy: Overview RNA interference (RNAi) is ... Read More
-
Global Antisense and RNAi Therapeutics Market Report and Forecast 2023-2031
... market is anticipated to grow at a CAGR of 8.5% during the forecast period of 2023-2031 to attain a value of USD 3.56 billion by 2031. Antisense and RNAi Therapeutics Market: Introduction Antisense and RNAi ... Read More
-
Global Antisense and RNAi Therapeutics Drug Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Antisense and RNAi Therapeutics Drug is estimated to increase from US$ million in 2022 to US$ million ... Read More
-
Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers)
... provide more effective treatment options for a wide range of disorders, with fewer side effects. These therapies are currently being developed using different types of RNA-based molecules, including coding RNAs (such as mRNA) and non-coding ... Read More
-
Global RNAi Medicine Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. United States market for RNAi Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Global RNA Interference (RNAi) Drug Delivery Market Growth 2023-2029
... Delivery sales in 2022, providing a comprehensive analysis by region and market sector of projected RNA Interference (RNAi) Drug Delivery sales for 2023 through 2029. With RNA Interference (RNAi) Drug Delivery sales broken down by ... Read More
Research Assistance
